Innate Pharma (IPHA) Enterprise Value Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Innate Pharma | 199.64 Mn | 199.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53.73% |
| Jun 30, 2025 | 17.29% |
| Dec 31, 2024 | 13.24% |
| Jun 30, 2024 | 10.14% |
| Dec 31, 2023 | 3.92% |
| Jun 30, 2023 | 16.41% |
| Dec 31, 2022 | 24.47% |
| Jun 30, 2022 | 27.69% |
| Dec 31, 2021 | 24.17% |
| Jun 30, 2021 | 99.88% |
| Dec 31, 2020 | 25.37% |
| Jun 30, 2020 | -86,224.56% |
| Dec 31, 2019 | -26.69% |
| Dec 31, 2018 | -39.87% |